Flynn Alexandra, Macaluso Matthew, D'Empaire Inna, Troutman Megan M
Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita (Drs Flynn, Macaluso, and D'Empaire) and Via Christi Hospitals (Dr Troutman), Wichita, Kansas.
Prim Care Companion CNS Disord. 2015 May 21;17(3). doi: 10.4088/PCC.14r01738. eCollection 2015.
Undiagnosed and/or undertreated Wernicke's encephalopathy can result in permanent brain damage, long-term institutionalization, and death. The purpose of this article is to heighten clinical awareness of Wernicke's encephalopathy and shed light on its diagnosis and treatment, which are often inconsistent due to unclear diagnostic criteria and limited practice guidelines. An update on the management of Wernicke's encephalopathy is presented and several case reports and a quality improvement project from our hospital are described.
PubMed, the Cochrane Database of Systematic Reviews, and PsycINFO were searched for English-language articles published between January 1991 and January 2014 using combinations of the following keywords: Wernicke's encephalopathy, diagnosis, treatment/guideline(s), and thiamine.
The automated search identified over 500 articles. A manual review of the related citations and reference lists from articles of interest was also conducted. The articles reviewed were chosen on the basis of author consensus and because they represented expert opinion or the highest quality of evidence available.
Diagnostic criteria are reviewed in this article and should be used to diagnose Wernicke's encephalopathy with high sensitivity and specificity. The European Federation of Neurologic Societies and the Royal College of Physicians issued national guidelines for the diagnosis, prevention, and treatment of Wernicke's encephalopathy. No benchmark national guidelines for treating Wernicke's encephalopathy exist in the United States.
Whenever Wernicke's encephalopathy is suspected, treatment should be initiated immediately with intravenous thiamine because oral thiamine is inadequate for preventing permanent brain damage. An adequate dose of intravenous thiamine administrated in a timely manner is a safe and life-saving treatment for Wernicke's encephalopathy that could preserve brain cells and function.
未被诊断和/或治疗不足的韦尼克脑病可导致永久性脑损伤、长期住院治疗及死亡。本文旨在提高对韦尼克脑病的临床认识,并阐明其诊断和治疗方法,由于诊断标准不明确和实践指南有限,其诊断和治疗往往不一致。本文介绍了韦尼克脑病管理的最新情况,并描述了我院的几例病例报告和一个质量改进项目。
通过在PubMed、Cochrane系统评价数据库和PsycINFO中检索1991年1月至2014年1月发表的英文文章,检索词组合如下:韦尼克脑病、诊断、治疗/指南和硫胺素。
自动检索识别出500多篇文章。还对手动查阅了感兴趣文章的相关引文和参考文献列表。所审查的文章是根据作者共识选择的,因为它们代表了专家意见或现有最高质量的证据。
本文对诊断标准进行了综述,应用该标准诊断韦尼克脑病具有较高的敏感性和特异性。欧洲神经学会联合会和皇家内科医师学院发布了韦尼克脑病诊断、预防和治疗的国家指南。美国没有治疗韦尼克脑病的基准国家指南。
一旦怀疑患有韦尼克脑病,应立即开始静脉注射硫胺素进行治疗,因为口服硫胺素不足以预防永久性脑损伤。及时给予足够剂量的静脉注射硫胺素是治疗韦尼克脑病的一种安全且挽救生命的方法,可保护脑细胞和功能。